Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STIMBOX: Reboxetine and tDCS for Motor Function in Stroke
NCT00853866Phase 4Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Jan 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of reboxetine in ischemic stroke, sponsored by University Medical Center Hamburg-Eppendorf. Started Jan 2009; status: completed.
02
Drugs
reboxetine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00853866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00853866.